A&O instructed by Celltech on largest Euro biotech deal
Allen & Overy (A&O) is acting on what is believed to be Europe’s largest ever biotechnology deal. A&O has been instructed by biopharmaceutical group and long-term client Celltech. The deal is to license CDP870, an injectable medicine for rheumatoid arthritis, to Pharmacia Corporation. Celltech will receive an up-front payment of $50m (£34.5m). Then, dependent on […]